Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
TC Energy to issue first quarter 2024 results on May 3 and hold annual and special meeting of common shareholders on June 4
-
SAB Biotherapeutics Provides SAB-142 Trial Update
-
St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
-
Director/PDMR Shareholding
-
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
-
Flexible morals: A key reason American voters support divisive misinformation
-
Nevada Lithium provides positive update on Hydraulic Borehole Mining method and commences updated Preliminary Economic Assessment for Bonnie Claire Lithium Project, Nevada
-
Guardian Capital Announces April 2024 Cash Distributions for Guardian Capital ETFs
-
Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
-
Aya Gold & Silver Announces Robust Mineral Resource Estimate at Boumadine
-
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
-
Electrify Expo Industry Day Hosts Biggest Lineup of Speakers to Address Most Important Conversations in Electrification
-
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
-
Highest Performances Holdings Inc. (NASDAQ: HPH) Secures a Share Purchase Agreement from GEM Global Yield LLC SCS (“GEM”) for an Investment of up to US$500 Million
-
KEY Investment Partners Announces First Close of Second Flagship Fund, Expansion of Advisory Board
-
Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases
-
Beneficient Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
-
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
-
Lantronix Announces New FOX4 and Bolero 43 Edge Compute Trackers, Expanding Its Award-Winning Telematic Gateways Family
-
Multi Ways Partners with Papua New Guinea Forest Authority to Promote Economic Growth
-
Gray Television Stations Win Large Market and Small Market Service to America Awards
-
Company Provides 2024 Results of Operations
-
Imugene and Kincell Bio Announce Strategic Manufacturing and Process Development Partnership
-
Barrick On Track to Achieve 2024 Targets
-
Sol Systems and SOLARCYCLE Partner to Recycle Solar Panels, Ensuring Greener Solar Solutions
-
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
-
Solaris Resources to Commence Trading on NYSE American Under SLSR
-
Mayfair Gold Drills 1.97 g/t Au over 68.9m including 3.01 g/t Au over 12.5m at Fenn-Gib Footwall Zone
-
CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 30
-
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
-
Gen II Fund Services Transforms Its Global Service Capabilities with Successful Acquisition of Crestbridge
-
ARKO Corp. Subsidiary to Open New Handy Mart Store in Newport, North Carolina
-
CECO Environmental to Release First Quarter Earnings and Host Conference Call on April 30
-
Treace Announces First Annual National Bunion Day
-
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
-
Multitude SE - Managers' transactions - Vella
-
Multitude SE - Managers' transactions - Kabele
-
Multitude SE - Managers' transactions - Mäkelä
-
Multitude SE - Managers' transactions - Krause
-
Multitude SE - Managers' transactions - Chatterjee
-
Multitude SE - Managers' transactions - Kajakas
-
Multitude SE - Managers' transactions - Tiukkanen
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Multitude SE - Managers' transactions - Kumpulainen
-
Multitude SE - Managers' transactions - Jokela
-
Vistin Pharma ASA: Invitation to Q1 2024 conference call
-
Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement
-
SOFI Announces Monthly Distributions on $THTA (13.07%)
-
YieldMax™ ETFs Announces Monthly Distributions on Fund of Funds and Ultra ETFs
-
Hexagon Purus ASA: Minutes of Annual General Meeting

